TRH FERRING 200 micrograms/1 ml, solution for injection ampoule, 1 ml
Active ingredients: PROTIRÉLINE, PROTIRÉLINE ANHYDRE
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injectionampoule, 1 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- TRH FERRING 200 microgrammes/1 ml, solution injectable
- Pharmaceutical form
- solution injectable
- Route of administration
- intraveineuse
- Presentation description
- 1 ampoule unidose en verre de 1 ml
- Marketing authorisation holder
- FERRING (FRANCE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 30 Jun 2026
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68393033CIP73011704CIP133400930117040Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| PROTIRÉLINEsolution | — | SA |
| PROTIRÉLINE ANHYDREsolution | 0,200 mg · 1 ml de solution injectable | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.